Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback

Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) is one of the best penny stocks under $1 to buy now. On July 9, Aspire Biopharma Holdings announced positive initial consumer feedback for its new sublingual pre-workout supplement, called BUZZ BOMB.

The product features 50mg of caffeine and provides sustained energy and mental focus to athletes and fitness enthusiasts, using a sublingual nano technology that delivers caffeine rapidly to the bloodstream. This delivery method allows for nearly instant energy.

A line of biopharmaceutical products on a laboratory shelf waiting to be tested.

Aspire began a soft launch of BUZZ BOMB last month and introduced it to strength trainers, consultants, and fitness professionals. The company positions BUZZ BOMB as a science-driven brand focused on optimizing nutrition and performance. Initial production of BUZZ BOMB has already commenced, and the product will be available in 30-unit packs across 4 flavors.

Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) is an early-stage biopharmaceutical company that develops and markets disruptive technology for novel sublingual delivery mechanisms in the US.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.